News

Looking for a role that combines professional satisfaction with an incredible lifestyle? At Taupō Health Centre, we are proud to provide high-quality, equitable healthcare to our community – and we would love you to join us. Our clinic is a busy General Practice with an on-site Urgent Care Clinic, caring for approximately for 11,000 enrolled patients, as well as providing care for casual patients. We also provide after-hours support on Saturdays and Public Holidays on a rostered basis in...

Nurse Practitioner - Queenstown Queenstown Medical Centre has been part of the local community for more than 50 years. We’re proud of the trusted relationships we’ve built, within our team, with our patients, and across our wider community. With three practices located in Queenstown, Frankton, and Jacks Point, we offer a full range of primary care services, with urgent care provided from our Queenstown site. The Role We’re looking for an experienced NP who’s passionate about delivering...

We’re seeking Nurse Practitioners for contract roles across Auckland to provide weekly rounds to Aged Residential Care (ARC) facilities, delivering high-quality care to older patients with complex needs. Join us in Auckland, the City of Sails, where you’ll enjoy the autonomy of working in aged residential care, flexible contract opportunities, and the lifestyle benefits of a vibrant harbour city with beautiful beaches, diverse communities, and an outstanding work-life balance. You will...

These key messages, identified by Gout Action Aotearoa, a group of clinicians, researchers and organisations with a focus on improving the treatment and management of gout, are helpful when discussing gout with your patient and their whānau: Gout is not your fault. Gout is caused by too much uric acid in your body. The uric acid forms crystals in your joints, causing painful gout attacks. 90% of the uric acid in your body is caused by your genes and kidneys, while only 10% is caused by food...

Pharmac has decided to widen access to four funded medicines for people with type 2 diabetes: empagliflozin, empagliflozin with metformin, liraglutide and dulaglutide, from 1 September 2026. The medicines are already funded. The new eligibility criteria will allow people with type 2 diabetes, whose blood sugar levels remain high despite treatment with other funded diabetes medicines, to access these treatments. This change applies to empagliflozin, empagliflozin with metformin, liraglutide...

From 1 October 2026, the statin rosuvastatin will no longer require a Special Authority for funded access. This means it will be open listed and may be prescribed as a funded medicine to any New Zealander where clinically appropriate. You can read the notification on the Pharmac website here Please share this information: Please share this information with your colleagues and within your networks. If you have any questions regarding this supply issue, please contact enquiry@pharmac.govt.nz....